R1 Therapeutics expands Series A financing to $80.5 million with Samsara Biocapital
Reuters reports R1 Therapeutics expanded its Series A financing to $80.5 million, with investment from Samsara Biocapital.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
R1 Therapeutics Series A Financing Expanded To $80.5M With Samsara Biocapital Investment
R1 Therapeutics Series A Financing Expanded To $80.5M With Samsara Biocapital Investment